Peptide vaccination induces specific effector and memory T cells but fails to enhance preexisting T cell immunity

Peptide vaccination induces specific effector and memory T cells but fails to enhance preexisting T cell immunity

Bibliographic Details
Main Authors:	Thiel E, Asemissen AM, Nagorsen D, Keilholz U, Letsch A, Scheibenbogen C
Format:	Article
Language:	English
Published:	BMC 2004-07-01
Series:	Cancer Cell International

Similar Items

Vaccination with WT1 induces high frequency memory and effector T cells in peripheral blood and bone marrow associated with complete remission of recurrent AML
by: Thiel E, et al.
Published: (2004-07-01)

Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients <it>in vivo</it>: results from a randomized clinical trial of IL-2 with or without histamine (MP 104)
by: Gehlsen K, et al.
Published: (2004-07-01)

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
by: Ochsenreither Sebastian, et al.
Published: (2010-01-01)

T cell responses against tumor associated antigens and prognosis in colorectal cancer patients
by: Rivoltini Licia, et al.
Published: (2005-01-01)

Depletion of regulatory T cells augments a vaccine-induced T effector cell response against the liver-stage of malaria but fails to increase memory.
by: Maria del Rosario Espinoza Mora, et al.
Published: (2014-01-01)

Generation of Effector Memory T Cell-Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination
by: Li, Adrienne Victoria, et al.
Published: (2014)

Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment.
by: Jingyao Zhang, et al.
Published: (2013-01-01)

A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses
by: Ying-Chyi Song, et al.
Published: (2020-02-01)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
by: Essie Komla, et al.
Published: (2021-06-01)

Schistosoma mansoni : macrophages as the effector cells of lung-phase immunity in vaccinated mice
by: Menson, Essie Natasha
Published: (1989)

Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
by: Gounwa Awad, et al.
Published: (2021-06-01)

Relevance of long-lived CD8+ T effector memory (TEM) cells for protective immunity elicited by heterologous prime-boost vaccination.
by: José Ronnie Vasconcelos, et al.
Published: (2012-12-01)

Characterization of effector and memory T cell subsets in the immune response to bovine tuberculosis in cattle.
by: Mayara F Maggioli, et al.
Published: (2015-01-01)

Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response
by: John Reiser, et al.
Published: (2016-01-01)

Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia
by: Alessandro Mauriello, et al.
Published: (2021-08-01)

Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model.
by: Simon H Apte, et al.
Published: (2012-01-01)

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells.
by: Joanne M Lumsden, et al.
Published: (2011-01-01)

Preexisting Immunity to Pandemic (H1N1) 2009
by: Zheng Xing, et al.
Published: (2009-11-01)

A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity
by: Pradeep K. Rai, et al.
Published: (2017-10-01)

Distinct Immune Profiles of Exhausted Effector and Memory CD8+ T Cells in Individuals With Filarial Lymphedema
by: Sacha Horn, et al.
Published: (2021-08-01)

Virulence of a virus: How it depends on growth rate, effectors, memory cells, and immune escape
by: Hara, A., et al.
Published: (2021)

Immunogenicity of cell death driven by immune effectors
by: Giulia Petroni
Published: (2020-06-01)

An effector Peptide family required for Drosophila toll-mediated immunity.
by: Alexa W Clemmons, et al.
Published: (2015-04-01)

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
by: Michelle Coureau, et al.
Published: (2020-05-01)

Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine.
by: Géraldine Arrode-Brusés, et al.
Published: (2014-01-01)

Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation
by: Asiel Arce-Sillas, et al.
Published: (2016-01-01)

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
by: Aseem Pandey, et al.
Published: (2012-01-01)

Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells
by: Coffer PJ, et al.
Published: (2011-09-01)

Memory T cells: effectors, regulators and implications for transplant tolerance
by: Yu-Qun eZeng, et al.
Published: (2016-01-01)

Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors.
by: Iryna Dekhtiarenko, et al.
Published: (2016-12-01)

Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status.
by: Anon Srikiatkhachorn, et al.
Published: (2012-01-01)

Preregistration of Analyses of Preexisting Data
by: Gaëtan Mertens, et al.
Published: (2019-08-01)

Protection by and maintenance of CD4 effector memory and effector T cell subsets in persistent malaria infection.
by: Michael M Opata, et al.
Published: (2018-04-01)

Immune effectors responsible for the elimination of hyperploid cancer cells
by: Fernando Aranda, et al.
Published: (2018-08-01)

Emerging Evidence for Platelets as Immune and Inflammatory Effector Cells
by: Matthew Thomas Rondina, et al.
Published: (2014-12-01)

Tissue specific heterogeneity in effector immune cell response
by: Saba eTufail, et al.
Published: (2013-08-01)

Study on the Effects of Pentoxifylline and Triptolideon Immune Effector Cells
by: Yu-Ju Cheng, et al.
Published: (2009)

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease
by: Hui Tang, et al.
Published: (2021-02-01)

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
by: Al-Samkari, H., et al.
Published: (2022)

Subversion of cell-autonomous immunity and cell migration by Legionella pneumophila effectors
by: Sylvia eSimon, et al.
Published: (2015-09-01)